Suono Bio

Developer of technology to enable ultra-rapid delivery of therapeutics to the gastrointestinal tract

placeCambridge, Massachusetts, United States calendar_todayFounded 2015 groups13 employees language suonobio.com

Innovation

7 patent families — focus: Human necessities; filing pace slowing. Cited 85 times.

YearFilings
20202
20212
20224
20232
20244

Investor mix

11 investors on record; lead investors include Axil Capital, Mizuho Sc.

Investor typeCountShare
Venture capital982%
Other / undisclosed218%
Coming soon